Previous 10 | Next 10 |
InMode has produced excellent financial results since listing in 2019. The company continues to have strong US performance and lots of expansion opportunities internationally. InMode needs to continue its product diversification and product innovation drive. For further deta...
InMode to Present at the UBS Global Healthcare Virtual Conference PR Newswire YOKNEAM, Israel , May 13, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that management will p...
InMode is a leader in the medical aesthetic devices industry and blows competitors out of the water when comparing financial metrics. The company still possesses many traits of a multi-bagger, such as having high revenue growth, stable margins, and high returns on capital. Our upd...
Image source: The Motley Fool. InMode Ltd. (NASDAQ: INMD) Q1 2021 Earnings Call May 05, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: InMode Ltd. (INMD) Q1 2021 Earnings Call Transcript
InMode Ltd (INMD) Q1 2021 Earnings Conference Call May 05, 2021, 08:30 ET Company Participants Miri Segal - MS-IR Moshe Mizrahy - Chairman & CEO Shakil Lakhani - President, North America Yair Malca - CFO Spero Theodorou - Chief Medical Officer Conference Call Participants Matt Taylor - UB...
InMode Reports First Quarter 2021 Financial Results: Quarterly Revenues of $65.5 Million Represent 62% Year over Year Growth. GAAP Earnings per Share of $0.63, 320% Year over Year Growth PR Newswire YOKNEAM, Israel, May 5, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: IN...
Shares of InMode Ltd. (NASDAQ:INMD) traded today at $89.59, eclipsing its 52-week high. So far today approximately 307,000 shares have been exchanged, as compared to an average 30-day volume of 644,000 shares. Over the past year, InMode Ltd. has traded in a range of $21.68 to $89.59 and ...
InMode Ltd. (NASDAQ:INMD) traded today at a new 52-week high of $84.98. This new high was reached on below average trading volume as 307,000 shares traded hands, while the average 30-day volume is approximately 737,000 shares. InMode Ltd. share prices have moved between a 52-week high of...
InMode ([[INMD]] +4.4%) announces preliminary Q121 results, with revenue expected in the range of $65.0M to $65.4M vs. $51.14M consensus.Non-GAAP EPS expected in the range of $0.65 to $0.67 vs. $0.46 consensus.Company expects Non-GAAP gross margin for FY21 in the range of 84% to 86%...
InMode Expects First Quarter 2021 Revenue Between $65.0-$65.4M, Non-GAAP Earnings per Diluted Share Between $0.65-$0.67 Conference call to be held on May 5 at 8:30 a.m. Eastern Time PR Newswire YOKNEAM, Israel, April 12, 2021 /PRNewswire/ -- InMode Ltd. (Nas...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 06:00:08 ET Matthew Taylor from Jefferies issued a price target of $19.00 for INMD on 2024-07-23 05:00:00. The adjusted price target was set to $19.00. At the time of the announcement, INMD was trading at $17.75. The overall price target consensus is at $34.50...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...